← Back to Clinical Trials
Recruiting NCT06081387

NCT06081387 The Effect of Aerobic and Resistance Training in Patients With Type 2 Diabetes on Vitamin D Treatment

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06081387
Status Recruiting
Phase
Sponsor University Ramon Llull
Condition Diabetes Mellitus, Type 2
Study Type INTERVENTIONAL
Enrollment 80 participants
Start Date 2025-10-01
Primary Completion 2026-01-01

Trial Parameters

Condition Diabetes Mellitus, Type 2
Sponsor University Ramon Llull
Study Type INTERVENTIONAL
Phase N/A
Enrollment 80
Sex ALL
Min Age 40 Years
Max Age N/A
Start Date 2025-10-01
Completion 2026-01-01
Interventions
Resistance training

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The purpose of this study protocol is to assess the effect of concurrent aerobic and resistance training in patients with type 2 diabetes on vitamin D treatment

Eligibility Criteria

Inclusion Criteria: * Adults (females or males) older than 18 years old with a diagnosis of T2D in the clinic database * Patients who have been taking the combination therapy of metformin + sodium-glucose transport protein 2 inhibitors (iSGLT2), as recommended by the redGDPS 2023, with stable medication for the past 6 months. * Diabetic patients taking prescribed VitD treatment for at least 6 months (intervention group) and diabetic patients not taking prescribed VitD (control group) * Patients who signed the informed consent * Patients capable of performing mild to moderate physical activity (to walk steadily and independently for at least 6 minutes) Exclusion Criteria: * Patients taking other medication different than metformin + iSGLT2 (including combinations and insulin) * Patients taking polyvitaminic supplementation at the inclusion for at least, 1 month before the intervention * Female subjects who are pregnant * Patients who did not sign the informed consent

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology